ARCHIVES

Two Conflicting Studies Presented at ASCO 2013, FDA Called Upon To Sort Through The Data

This article is from The Cancer Letter archive.

Vol. 36 No. 6 | June 28, 2013

Download PDF Visit The Full Archive

Related Articles

In Brief: Disapproved CCP Wins Appeal; New Review; Trish Greene Named ACS VP For Nursing

February 26, 1988

Adjuvant XELOX More Effective Than 5-FU/LV For Stage III Colon Cancer

January 29, 2010

Richard Wood, ICRF, Accepts Appointment At Pittsburgh.

March 2, 2001

ASCO Recommends Aromatase Inhibitors As Adjuvant For Some Breast Cancer

July 30, 2010

In Brief: New NCAB Members Briefed At Orientation Wogan Resigns From Board; Parry Names NCCP Deputy

September 10, 1982

NCI Says Breast Cancer Rate In Marin Matches Other West Coast Counties

April 18, 2003